RBC Capital Remains a Buy on Physicians Realty Trust

By Austin Angelo

RBC Capital analyst Frank Morgan reiterated a Buy rating on Physicians Realty Trust (NYSE: DOC) on November 13 and set a price target of $21. The company’s shares closed yesterday at $18.19.

According to TipRanks.com, Morgan is a 4-star analyst with an average return of 7.1% and a 57.8% success rate. Morgan covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Fresenius Medical Care Corp, and Quest Diagnostics Inc.

Currently, the analyst consensus on Physicians Realty Trust is Strong Buy and the average price target is $20.33, representing an 11.8% upside.

In a report issued on November 3, Stifel Nicolaus also reiterated a Buy rating on the stock with a $22 price target.

The company has a one-year high of $21.85 and a one-year low of $17.25. Currently, Physicians Realty Trust has an average volume of 1.2M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Physicians Realty Trust operates as a real estate investment trust, which leases and manages healthcare properties. It is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties which are leased to physicians, hospitals, and healthcare delivery systems.